Curation SCA10 ATXN10

GeneATXN10
DiseaseSCA10
InheritanceAD
Score

12 + 2 = 14 / 18

Genetic + experimental = total

Classification
0
18
Refuted
Moderate
Definitive
Last Updated08/12/2025
Pubs Reviewed4
Publication Span25.41 years
Publication Interval25.41 years
CuratorMacayla Weiner
ContributorsLaurel Hiatt, Harriet Dashnow
Description

SCA10 is an autosomal dominant spinocerebellar ataxia characterized by cerebellar ataxia with variable seizures, caused by a large ATTCT pentanucleotide repeat expansion in intron 9 of ATXN10. Genetic evidence includes linkage to chromosome 22q13, segregation/haplotype evidence in SCA10 families, absence or low frequency of disease-associated haplotypes/expansions in controls, and repeat-size/structure variability. Experimental evidence supports ATXN10/Atx-10 as an important neuronal and cellular protein.

Genetic evidence

Total:12

Category
Type
Citation
Score
Details
Singular Evidence
Probands
6

Six unrelated SCA10 families were analyzed (three Brazilian, two Mexican mapping families, and one early-onset Mexican patient), comprising 34 SCA10 expansion carriers and 20 relatives with cerebellar ataxia and variable seizures.

Collective Evidence
Allele
1

An inverse correlation has been observed between the expansion size and the age of onset (r2=0.34, P=0.018).

Collective Evidence
Segregation
1.5

A four-generation Mexican-American autosomal dominant SCA pedigree showed linkage to chromosome 22q13, with maximum two-point LOD score 4.30 at D22S928 and D22S1161 (θ=0) and informative haplotypes defining recombination events.

Statistics
Case-control data
6

SCA10 expanded chromosomes shared conserved intragenic/flanking haplotypes; 154 control chromosomes from Brazilian, Mexican, and Portuguese populations were analyzed for haplotype frequencies and showed low-frequency disease-associated flanking haplotypes.

Experimental evidence

Total:2

Category
Type
Citation
Score
Details
Function
Regulatory impact
1

pmid:11017075 notes that the large intronic ATTCT expansion could affect ATXN10 transcription or post-transcriptional processing, but preliminary northern blot data showed no obvious SCA10 mRNA change in patient lymphoblastoid cells; pmid:38467784 provides review-level context that STR sequence composition can affect gene expression.

Functional Alteration
Patient cells
1

Patient lymphoblastoid cells were used for western blotting to exclude expanded polyglutamine proteins and for preliminary northern blot analysis showing no obvious SCA10 mRNA level change; disease-relevant patient-cell functional alteration was not demonstrated.

Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.